By Counterforce Health Team in Tegsedi (inotersen) —

How to Get Tegsedi (inotersen) Covered by Aetna CVS Health in Georgia: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Tegsedi (inotersen) Covered by Aetna CVS Health in Georgia

Tegsedi (inotersen) requires prior authorization from Aetna CVS Health, mandatory REMS enrollment, confirmed hATTR polyneuropathy diagnosis, and baseline lab monitoring. The fastest path to approval: 1) Enroll prescriber and patient in Tegsedi REMS, 2) Submit PA with genetic testing and lab results via Aetna provider portal, 3) If denied, file internal appeal within 180 days, then external review with Georgia DOI within 60 days. Note: Akcea discontinued Tegsedi in September 2024—verify availability and consider alternatives like Onpattro or Amvuttra.

Table of Contents

  1. Understanding Tegsedi Coverage Requirements
  2. Step-by-Step: Fastest Path to Approval
  3. Common Denial Reasons & How to Fix Them
  4. Appeals Playbook for Aetna CVS Health in Georgia
  5. Medical Necessity Letter Template
  6. External Review Process in Georgia
  7. Costs & Patient Assistance Options
  8. FAQ

Understanding Tegsedi Coverage Requirements

Aetna CVS Health requires several key criteria for Tegsedi (inotersen) coverage:

Requirement Specific Criteria Documentation Needed
Prior Authorization Required for all Aetna plans Member ID, prescriber letter, ICD-10 E85.1
REMS Enrollment Prescriber and patient must enroll at tegsedirems.com Enrollment confirmation, certification proof
Diagnosis Age ≥18; confirmed TTR gene mutation + polyneuropathy Genetic report, EMG/nerve conduction studies
Baseline Labs Platelets ≥100K/μL, kidney function tests, CBC within 30 days Lab results + ongoing monitoring plan
Prescriber Neurologist or amyloidosis specialist Specialist consultation notes
Important: Akcea Therapeutics discontinued Tegsedi commercial availability in September 2024. Verify current availability with your specialty pharmacy and consider FDA-approved alternatives like Onpattro (patisiran) or Amvuttra (vutrisiran).

Step-by-Step: Fastest Path to Approval

1. REMS Enrollment (Required Before Prescribing)

Who: Prescriber and patient
Timeline: 1-2 business days
Action: Visit tegsedirems.com to complete training and enrollment. Prescribers must certify understanding of thrombocytopenia and glomerulonephritis risks.

2. Gather Required Documentation

Who: Clinic staff
Timeline: 3-5 days
Documents needed:

  • TTR genetic testing results
  • Baseline labs (platelets, kidney function, CBC)
  • Neurologist consultation notes
  • Prior therapy history (if applicable)

3. Submit Prior Authorization

Who: Prescriber
How: Aetna provider portal or fax to CVS Caremark
Phone: 1-866-814-5506 (specialty)
Timeline: 1-7 day response

4. Track Status and Follow Up

Who: Clinic or patient
Action: Call Aetna at 1-855-240-0535 for PA status updates

Common Denial Reasons & How to Fix Them

Denial Reason How to Overturn Required Documentation
Missing REMS enrollment Complete enrollment at tegsedirems.com REMS confirmation certificates
Insufficient genetic testing Provide TTR mutation analysis Genetic lab report with specific mutation
Inadequate lab monitoring plan Submit detailed monitoring protocol Lab schedule, platelet/kidney monitoring plan
No specialist prescription Get neurologist consultation Specialist evaluation and treatment plan
Step therapy not met Document contraindications to alternatives Medical records showing prior failures/intolerances

Counterforce Health helps patients and clinicians navigate these complex approval processes by turning denial letters into targeted, evidence-backed appeals that align with each payer's specific requirements.

Appeals Playbook for Aetna CVS Health in Georgia

Internal Appeals Process

Level 1: Standard Appeal

Expedited Appeal

  • When: Urgent medical situations
  • Timeline: 72 hours
  • How: Mark "Urgent" on appeal form and provide clinical justification

Peer-to-Peer Review

Request through Aetna provider services at 1-866-814-5506. Prepare a 5-10 minute script covering:

  • Confirmed hATTR diagnosis with genetic testing
  • Disease progression documentation
  • Prior therapy failures or contraindications
  • Clinical trial data supporting Tegsedi efficacy

Medical Necessity Letter Template

[Neurologist Letterhead]

Date: [Current Date]
To: Aetna Medical Director
Re: Medical Necessity for Tegsedi (inotersen)
Patient: [Name], DOB: [Date], Member ID: [Number]
Diagnosis: hATTR Amyloidosis with Polyneuropathy (ICD-10: E85.1)

Dear Medical Director,

I am requesting approval for Tegsedi (inotersen) for my patient with hereditary transthyretin-mediated amyloidosis with polyneuropathy.

Clinical Background:

  • Confirmed TTR gene mutation: [specify mutation, e.g., Val122Ile]
  • Baseline neuropathy impairment score: [score]
  • Disease stage: [1 or 2] with progressive sensorimotor symptoms
  • Current functional limitations: [specific impairments]

Medical Necessity:

  • FDA-approved indication for hATTR polyneuropathy
  • Clinical trials demonstrate 66% reduction in neuropathy progression
  • Patient enrolled in mandatory REMS program
  • Baseline labs meet safety requirements (platelets >100K/μL)

Prior Treatments: [Document any previous therapies and outcomes]

Monitoring Plan: Weekly platelet monitoring, kidney function assessment per FDA labeling

Denial of this evidence-based therapy would expose the patient to irreversible neurologic decline. I am available for peer-to-peer discussion.

Sincerely,
[Physician Name and Credentials]

External Review Process in Georgia

If Aetna denies your internal appeal, Georgia residents have the right to external review through the Georgia Department of Insurance.

Key Requirements:

  • Deadline: 60 days from final internal denial notice
  • Cost: Free for patients
  • Eligibility: Fully insured plans (not self-funded employer plans)
  • Contact: Georgia DOI Consumer Services at 1-800-656-2298

Timeline:

  • Standard review: 30 business days
  • Expedited review: 72 hours (for urgent cases)

How to File:

  1. Call Georgia DOI Consumer Services
  2. Submit external review application with supporting documents
  3. Include final denial letter and medical records
  4. Decision is binding on Aetna
Note: Georgia's external review process has helped many patients overturn wrongful denials for specialty medications. The independent medical reviewers focus solely on medical necessity without considering cost.

Costs & Patient Assistance Options

Insurance Coverage:

  • Aetna typically covers Tegsedi as Tier 4 specialty drug
  • Prior authorization reduces coverage to applicable copay/coinsurance

Patient Assistance:

  • Manufacturer copay assistance (verify current availability given discontinuation)
  • Foundation grants through organizations like HealthWell Foundation
  • State pharmaceutical assistance programs

Alternative Funding:

  • Clinical trials for newer hATTR treatments
  • Compassionate use programs

Counterforce Health specializes in helping patients access these assistance programs while navigating the insurance approval process, ensuring no stone is left unturned in securing coverage.

FAQ

Q: How long does Aetna prior authorization take for Tegsedi? A: Standard PA decisions typically take 1-7 business days. Expedited reviews for urgent cases are completed within 24 hours.

Q: What if Tegsedi is not on Aetna's formulary? A: Submit a formulary exception request with clinical documentation. Non-formulary drugs can be covered with appropriate medical justification.

Q: Can I appeal if I miss the 180-day deadline? A: Georgia law is strict about appeal deadlines. Contact Aetna immediately if you've missed the deadline—some circumstances may allow late filing.

Q: What's the difference between medical and pharmacy benefit coverage? A: Tegsedi is typically covered under the pharmacy benefit. Check your specific plan documents or call member services at the number on your insurance card.

Q: Are there alternatives if Tegsedi is denied? A: Yes. FDA-approved alternatives include Onpattro (patisiran) and Amvuttra (vutrisiran). Your neurologist can help determine the best option.

Q: How do I verify my plan type for external review eligibility? A: Contact your HR department or call Aetna member services. Self-funded employer plans follow federal ERISA rules, not Georgia's external review process.

This article provides educational information about insurance coverage and appeals processes. It is not medical advice. Always consult with your healthcare provider about treatment decisions and contact official sources for the most current information about coverage requirements and deadlines.

Need help with your appeal? Counterforce Health transforms insurance denials into targeted, evidence-backed appeals by analyzing denial letters, plan policies, and clinical notes to identify the specific denial basis and draft point-by-point rebuttals aligned to each payer's own rules.

Sources & Further Reading

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.